Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ05
- Pharmacological subgroupJ05A
- Chemical subgroupJ05AXOther antivirals
- Chemical substanceJ05AX18Letermovir
Where it is registered
Each register and historical list with its number of registrations and a few of them.
At a glance
- ATC code
- J05AX18
- ATC group
- Anti-infectives for systemic use
- Registers
- 10
- Historical lists
- 1
- Registrations
- 33
- With their own page
- 26
- Companies
- 12
All medicines with Letermovir
Human medicines from every register that match Letermovir by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
33 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Lupin-Letermovir | Canada | 480 MG | Tablet | Marketed | Lupin Pharma Canada Limited |
| Lupin-Letermovir | Canada | 240 MG | Tablet | Marketed | Lupin Pharma Canada Limited |
| Prevymis | United States | 240MG, 480MG | tablet | Marketed | Merck Sharp Dohme |
| Prevymis | United States | 240MG/12ML, 480MG/24ML | solution | Marketed | Merck Sharp Dohme |
| Prevymis | United States | 120MG/PACKET, 20MG/PACKET | pellets | Marketed | MSD |
| Prevymis | European Union | Authorised | Merck Sharp & Dohme B.V. | ||
| Prevymis 240 MG Comprimidos Recubiertos con Pelicula | Spain | 240 mg | comprimido recubierto con película | Marketed | Merck Sharp & Dohme B.V. |
| Prevymis 480 MG Comprimidos Recubiertos con Pelicula | Spain | 480 mg | comprimido recubierto con película | Marketed | Merck Sharp & Dohme B.V. |
| Prevymis 240 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Merck Sharp & Dohme B.V. | |
| Prevymis 480 mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Merck Sharp & Dohme B.V. | |
| Prevymis 120 mg granulaat in sachet | Netherlands | Granulaat | Authorised | Merck Sharp & Dohme B.V. | |
| Prevymis 20 mg granulaat in sachet | Netherlands | Granulaat | Authorised | Merck Sharp & Dohme B.V. | |
| Prevymis 240 mg, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Merck Sharp & Dohme B.V. | |
| Prevymis 240 MG Concentrado Para Solucion Para Perfusion | Spain | 240 mg | concentrado para solución para perfusión | Authorised | Merck Sharp & Dohme B.V. |
| Prevymis 480 mg, concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Merck Sharp & Dohme B.V. | |
| Prevymis 480 MG Concentrado Para Solucion Para Perfusion | Spain | 480 mg | concentrado para solución para perfusión | Authorised | Merck Sharp & Dohme B.V. |
| Prevymis | Canada | 20 MG / ML | Solution | Marketed | Merck Canada INC |
| Prevymis | Canada | 480 MG | Tablet | Marketed | Merck Canada INC |
| Prevymis | Canada | 240 MG | Tablet | Marketed | Merck Canada INC |
| Prevymis Film Coated Tablet 240MG | Singapore | 240.0mg | tablet, film coated | Authorised | MSD Pharma (Singapore) Pte. LTD. |
| Prevymis Film Coated Tablet 480MG | Singapore | 480.0mg | tablet, film coated | Authorised | MSD Pharma (Singapore) Pte. LTD. |
| Prevymis Concentrate for Solution for Infusion 20MG/ML | Singapore | 20mg/ml | infusion, solution concentrate | Authorised | MSD Pharma (Singapore) Pte. LTD. |
| Privymtra | Brazil | Authorised | Merck Sharp & Dohme Farmaceutica Ltda. | ||
| Privymtra | Brazil | Authorised | Merck Sharp & Dohme Farmaceutica Ltda. | ||
| Prevymis | Croatia | Marketed |